GlaucomaCME
VIDEOCMEABO MOC

Understanding the Role of Nitric Oxide in Glaucoma Management

Author(s)/Faculty: Jason Bacharach, MD; Sarah H. Van Tassel, MD; Thomas W. Samuelson, MD
Release Date: 7/16/2021Expiration Date: 7/15/2022
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 0.5
Content Type: VideoProvider:
Glaucoma is a leading cause of blindness worldwide, with an estimated 80 million people living with this condition as of 2020. Many individuals with glaucoma remain at risk for disease progression due to inadequate control of intraocular pressure (IOP) with traditional medical options. Recent studies have demonstrated that nitric oxide (NO) signaling plays a key role in IOP regulation via its action on the conventional outflow pathway, and NO-donating agents produce significant functional improvements in this pathway. In this educational program, experts in the field discuss the role of NO in IOP reduction, and review clinical studies assessing NO-donating therapies in the treatment of glaucoma. Clinical case discussion will provide further guidance for the integration of NO-donating therapies into practice.